Farmaceutica REMEDIA S.A.: Mail Voting for Extraordinary General Meeting of Shareholders (EGMS) Scheduled for 21/22.08.2024
As a shareholder of Farmaceutica REMEDIA S.A., your participation in the corporate decision-making process is invaluable. With the upcoming Extraordinary General Meeting of Shareholders (EGMS), scheduled for August 21/22, 2024, we are facilitating the process for our shareholders to exercise their voting rights via mail. This initiative ensures your voice is heard, even if you are unable to attend in person.
Exercise Your Voting Rights
In alignment with the provisions of Law no. 297-2004, article 100, paragraph 2, regarding the procedure for mail voting, shareholders are encouraged to exercise their voting rights for the shares registered in their name in the Shareholders’ Register maintained by the Central Depository as of the reference date.
Agenda Items for Vote
The following items are scheduled for discussion and vote:
- Extension of Credit Facility: Proposal for the approval to supplement the Global Operating Ceiling credit facility provided by Banca Transilvania SA. The request is to increase the facility from RON 90,000,000 to RON 100,000,000. This includes the approval for the establishment or maintenance of collateral which may exceed 20% of the total fixed assets, less receivables.
Voting Options: In favour, Opposed, Abstained
- Empowerment to Sign Credit and Mortgage Contracts: Proposal to authorize Mr. Cristian Plocon, a member of the Board of Administrators, to sign on behalf of Farmaceutica REMEDIA S.A. the credit contract(s), related mortgage and/or real estate contracts, and any additional documents necessary for the execution of the agreements with the selected bank.
Voting Options: In favour, Opposed, Abstained
- Board of Administrators’ Authority: Proposal to empower the Board of Administrators to issue decisions related to the above-mentioned credit facility extension, the establishment of collaterals, and to grant mandates for signing all ensuing documents post the Extraordinary General Meeting of Shareholders.
Voting Options: In favour, Opposed, Abstained
In consideration of your involvement and the importance of these decisions to our company’s future, we highly encourage all shareholders to participate by mail voting. Your vote is crucial for the strategic direction and continued success of Farmaceutica REMEDIA S.A.
To facilitate a seamless process, please ensure your vote is clearly marked on the mail voting form provided and return it within the specified timeframe. This form acts as a direct channel for you to exercise your shareholder rights and influence the decision-making process at the forthcoming EGMS.
We thank you for your continued trust and support in Farmaceutica REMEDIA S.A. Your active participation is key to our collective success and future growth.
